Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$6.54 - $9.08 $11,601 - $16,107
-1,774 Reduced 0.33%
533,322 $3.73 Million
Q2 2022

Aug 08, 2022

SELL
$6.82 - $13.82 $11,962 - $24,240
-1,754 Reduced 0.33%
535,096 $3.65 Million
Q1 2022

May 26, 2022

BUY
$11.65 - $15.28 $976,805 - $1.28 Million
83,846 Added 18.51%
536,850 $7.57 Million
Q1 2022

May 05, 2022

SELL
$11.65 - $15.28 $968,045 - $1.27 Million
-83,094 Reduced 15.5%
453,004 $6.39 Million
Q4 2021

Feb 14, 2022

BUY
$12.37 - $16.77 $2.04 Million - $2.77 Million
165,269 Added 44.57%
536,098 $7.77 Million
Q3 2021

Nov 09, 2021

BUY
$13.7 - $17.25 $5.08 Million - $6.4 Million
370,829 New
370,829 $5.25 Million

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $659M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.